StudyFinder

Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years

Recruiting

This study will enroll children aged 6 to 12 years who have difficulty in maintaining a healthy weight and see if the medication Vyvanse may help them to reduce their weight.

I'm interested

Male or Female
Up to 18 years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• children 6 to 12 years old
• severe obesity defined as BMI greater than or equal to 1.2 times the 95th percentile
• failed attempt of lifestyle therapy
Exclusion Criteria:

• significant congenital or structural heart disease or arrhythmia
• hypertension
• history of chemical dependency
• Diabetes mellitus (type 1 or 2)
• current or recent ( less than 3 months ago) use of anti-obesity medication(s)
• additional medical or mental health conditions (study staff will review)

Children's Health, Diabetes & Endocrine

healthy weight, Obesity

Nina Jacobs - njacobs@umn.edu
Claudia Fox
EARLY_PHASE1
STUDY00019097
See this study on ClinicalTrials.gov

Back